Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • pharma-news

    pharma-news - Page 63

    Alembic Pharma gets USFDA nod for generic version of Jadenu, Exjade tablet to treat chronic iron overload

    Alembic Pharma gets USFDA nod for generic version of Jadenu, Exjade tablet to treat chronic iron overload

    Farhat Nasim23 Nov 2019 12:34 PM IST
    Deferasirox tablets are generic versions of Novartis Pharmaceuticals Corporation’s Jadenu tablets and Exjade tablets for oral suspension in the same...
    Johnson and Johnson found negligent in landmark vaginal mesh lawsuit in Australia

    Johnson and Johnson found negligent in landmark vaginal mesh lawsuit in Australia

    Medical Dialogues Bureau23 Nov 2019 9:18 AM IST
    Australia's Federal Court found that Johnson and Johnson (JnJ) subsidiary Ethicon had sold the devices (pelvic mesh implants) without warning women...
    Bayer, WHO collaborate to combat taeniasis, neurocystercosis

    Bayer, WHO collaborate to combat taeniasis, neurocystercosis

    Medical Dialogues Bureau23 Nov 2019 9:17 AM IST
    With praziquantel (“Biltricide”) and niclosamide (“Yomesan”) Bayer will provide two effective treatments, which are part of the latest WHO Model List...
    Achillion Pharma PNH treatment Danicopan gets European Medicines Agency PRIME Designation

    Achillion Pharma PNH treatment Danicopan gets European Medicines Agency PRIME Designation

    Medical Dialogues Bureau23 Nov 2019 9:00 AM IST
    New Delhi: Achillion Pharmaceuticals, Inc. a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients and families...
    Chinese strategy: Dr Reddys outsources part manufacturing to local parties

    Chinese strategy: Dr Reddy's outsources part manufacturing to local parties

    Medical Dialogues Bureau22 Nov 2019 12:50 PM IST
    Hyderabad: Betting big on the Chinese market, Dr Reddy's Laboratories which has plans to launch over 70 products in the East Asian country has started...
    Cabinet nod to extension of pharmaceuticals purchase policy for pharma PSUs

    Cabinet nod to extension of pharmaceuticals purchase policy for pharma PSUs

    Medical Dialogues Bureau22 Nov 2019 12:28 PM IST
    New Delhi: The Union Cabinet on Wednesday approved the extension of Pharmaceuticals Purchase Policy (PPP) for pharmaceutical Central Public Sector...
    FIRST: Roche wins DCGI nod for Atezolizumab to treat small-cell lung cancer

    FIRST: Roche wins DCGI nod for Atezolizumab to treat small-cell lung cancer

    Medical Dialogues Bureau22 Nov 2019 12:25 PM IST
    "Atezolizumab is the first cancer immunotherapy to receive approval from DCGI in India for the first-line treatment of extensive-stage small-cell lung...
    Laurus Labs gets 3 USFDA observations for Visakhapatnam facility

    Laurus Labs gets 3 USFDA observations for Visakhapatnam facility

    Medical Dialogues Bureau22 Nov 2019 12:08 PM IST
    The inspection of Visakhapatnam facility in Andhra Pradesh was completed with three observations, 'which are procedural in nature'. No data integrity...
    Zydus Cadila Desonide Cream, Isosorbide Dinitrate tablets get USFDA approval

    Zydus Cadila Desonide Cream, Isosorbide Dinitrate tablets get USFDA approval

    Medical Dialogues Bureau22 Nov 2019 11:55 AM IST
    Zydus Cadila has received approval from the US Food and Drug Administration (USFDA) for Isosorbide Dinitrate tablets for preventing attacks of chest...
    Alnylams rare genetic disorder drug gets early U.S. approval

    Alnylam's rare genetic disorder drug gets early U.S. approval

    Medical Dialogues Bureau21 Nov 2019 12:54 PM IST
    Alnylam Pharmaceuticals Inc on Wednesday received an early U.S. approval for its gene silencing drug to treat patients with a rare genetic disorder...
    Charity to pay $4 million to resolve U.S. pharma kickback probe

    Charity to pay $4 million to resolve U.S. pharma kickback probe

    Medical Dialogues Bureau21 Nov 2019 12:53 PM IST
    BOSTON - A Florida-based charity will pay $4 million to resolve claims that it acted as a conduit for companies including Biogen Inc and Novartis AG...
    China plans to add more drugs to price-slashing bulk-buy program

    China plans to add more drugs to price-slashing bulk-buy program

    Medical Dialogues Bureau21 Nov 2019 12:51 PM IST
    BEIJING: China will add more drugs to its bulk-buy program in an effort to curb high medicine prices, the country's cabinet said, in a move that could...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok